D.E. Shaw & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $439K | Buy |
+2,200
| New | +$435K | ﹤0.01% | 3915 |
|
|
2020
Q3 | – | Sell |
-46,487
| Closed | -$3.24M | – | 4002 |
|
|
2020
Q2 | $3.24M | Hold |
46,487
| – | – | ﹤0.01% | 2014 |
|
|
2020
Q1 | $2.11M | Buy |
+46,487
| New | +$2.63M | ﹤0.01% | 2123 |
|
|
2019
Q4 | – | Sell |
-42,960
| Closed | -$2.67M | – | 4073 |
|
|
2019
Q3 | $2.67M | Hold |
42,960
| – | – | ﹤0.01% | 2143 |
|
|
2019
Q2 | $3.06M | Buy |
42,960
+8,015
| +23% | +$590K | ﹤0.01% | 1951 |
|
|
2019
Q1 | $2.74M | Buy |
34,945
+6,251
| +22% | +$474K | ﹤0.01% | 1947 |
|
|
2018
Q4 | $2.43M | Buy |
28,694
+962
| +3% | +$103K | ﹤0.01% | 1993 |
|
|
2018
Q3 | $4.75M | Buy |
27,732
+2,084
| +8% | +$314K | 0.01% | 1612 |
|
|
2018
Q2 | $3.31M | Buy |
25,648
+9,618
| +60% | +$1.07M | ﹤0.01% | 1831 |
|
|
2018
Q1 | $1.65M | Buy |
+16,030
| New | +$1.59M | ﹤0.01% | 2176 |
|
|
2017
Q3 | – | Sell |
-4,488
| Closed | -$340K | – | 3523 |
|
|
2017
Q2 | $340K | Hold |
4,488
| – | – | ﹤0.01% | 2981 |
|
|
2017
Q1 | $296K | Buy |
+4,488
| New | +$295K | ﹤0.01% | 2970 |
|
|
2014
Q3 | – | Sell |
-18,114
| Closed | -$704K | – | 4259 |
|
|
2014
Q2 | $704K | Sell |
18,114
-46,647
| -72% | -$1.89M | ﹤0.01% | 3242 |
|
|
2014
Q1 | $2.72M | Buy |
64,761
+23,243
| +56% | +$969K | ﹤0.01% | 2080 |
|
|
2013
Q4 | $1.36M | Sell |
41,518
-58,990
| -59% | -$1.92M | ﹤0.01% | 2891 |
|
|
2013
Q3 | $2.71M | Buy |
100,508
+75,982
| +310% | +$2.14M | ﹤0.01% | 2155 |
|
|
2013
Q2 | $573K | Buy |
+24,526
| New | +$441K | ﹤0.01% | 3142 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC